Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

An evolved AAV variant enables efficient genetic engineering of murine T cells

Cell(2023)10.1016/j.cell.2022.12.022Source: DataRank Database

An evolved AAV variant enables efficient genetic engineering of murine T cells is a research paper published in Cell (2023). On theSindex it has a DataRank of 0. It has been cited 97 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access97 citations

Download PDF

Cite:

Linked data & code

geo nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 11.85)OA: hybridTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Jonathan Ark ORCID,Angela To ORCID,Sylvanie Clouden,Gabriella C. Reeder ORCID,Joseph J. Muldoon ORCID

Live enrichment

PubMed:36638795 PMC:PMC10540678 OpenAlex:https://openalex.org/W4315705270

NHLBI NIH HHS

Grant: R01 HL089221

NIGMS NIH HHS

Grant: R01 GM127708

NIAID NIH HHS

Grant: T32 AI007334

NHGRI NIH HHS

Grant: T32 HG002536

Howard Hughes Medical Institute

FWCI

11.85

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S0092867422015355/pdf

publisherhttp://www.cell.com/article/S0092867422015355/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867422015355?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867422015355?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2022.12.022

Fields of Study

CAR-T cell therapy researchCRISPR and Genetic EngineeringVirus-based gene therapy research

MeSH Terms

DependovirusAnimalsGenetic EngineeringT-LymphocytesGene TargetingMiceCRISPR-Cas Systems

Keywords

BiologyComputational biologyGeneticsT cellAAVgene targetingimmunologyGene EditingCrispr/cas9Car-t CellGenome Wide Crispr ScreenTrac-car

Sustainable Development Goals

SDG 0: Good health and well-being

An evolved AAV variant enables efficient genetic engineering of murine T cells

FAIR Checklist

Authors (18)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)